Stay updated with breaking news from Simple Western. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MINNEAPOLIS, May 22, 2024 /PRNewswire/ -- Bio-Techne Corporation and Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines...
Bio-Techne Corporation and Regulus Therapeutics Inc. announced continued technical and clinical collaboration following release of Regulus' positive topline results from the second cohort of patients...
In this article, Analytik Jena explains how to automate high-throughput western blotting in the drug discovery sector.
Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46.
Operator: Good morning, and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year 2024.